glp-1 receptor agonist news agonists for individualized treatment of type 2 diabetes mellitus How GLP-1 Receptor Agonists Evolved

More body fat means more baseline inflammation, which means a lower threshold for disease activation

In one study of 208 patients, 45 experienced 88 fractures, with Standardized Incidence Ratios (SIRs) of 2.9 in females and 3.4 in males

10.1161/CIRCULATIONAHA.121.057934 47 LambadiariV.PavlidisG.KousathanaF.VaroudiM.VlastosD.MaratouE.et al (2018)

Lilly is expecting another revenue rise of around 32% in 2025, and analysts are expecting it to grow its share of the GLP-1 market across diabetes and obesity (it ended 2024 with 34% compared with Novo Nordisks 63%)

Side Effects, Risks and Considerations While these medications are effective, there are some additional factors to consider prior to commencing treatment